RxDoctor Payments Data

Katherine Jones, OD

Optometrist · Murfreesboro, TNNPI 1023739505

Payments from drug & device makers

$1,044in general payments, 2019–2025

Across 26 payments — averaging $40.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Rxsight Inc$226
  • Glaukos Corporation$207
  • AbbVie$145
  • Johnson & Johnson Surgical Vision, Inc.$127
  • Dompe US, Inc.$120
  • Alcon$96
  • plus $122 from 4 others

What the payments were for

  • Food & beverage$1,044100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,044 in reported general payments places this provider in the 60th percentile of 1,122 optometrist providers in Tennessee.

See all optometrist providers in Tennessee

Medicare billing

Part B allowed, 2024
$99,802
Medicare patients
492
Services billed
1,259

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
LumiganBimatoprost103$39,355
RhopressaNetarsudil Mesylate45$17,892
RestasisCyclosporine12$13,428
RocklatanNetarsudil Mesylat/Latanoprost21$8,589
Alphagan PBrimonidine Tartrate27$7,532
CombiganBrimonidine Tartrate/Timolol16$6,019
Ketorolac Tromethamine149$5,850
SimbrinzaBrinzolamide/Brimonidine Tart28$5,800
Prednisolone Acetate157$5,436
Brimonidine Tartrate84$4,510
Brimonidine Tartrate-TimololBrimonidine Tartrate/Timolol31$3,822
Latanoprost348$3,702
Travoprost25$2,776
Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat145$2,144
Ofloxacin104$1,362

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieLumigan, Restasis, Alphagan P, Combigan$145$66,333158 claims
AlconSimbrinza$96$5,80028 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 1,122 optometrist providers in Tennessee.

Other optometrist in Murfreesboro

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →